Stock 4579 RAQUALIA PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus RaQualia Pharma Inc.

Equities

4579

JP3967150008

Delayed Japan Exchange
Other stock markets
 07:00:00 07/05/2024 BST 		5-day change 1st Jan Change
609 JPY +1.67% Intraday chart for RaQualia Pharma Inc. +2.35% -11.48%
03-26 RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others. CI
02-14 RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024 CI

Evolution of the average Target Price on RaQualia Pharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

0a377754f2b9ca58f7d5ed370af57cd.PkJ3jOrmnJ6DkxTKJ3aYQg7h3OxiUqkXcQTO5kymEgk.Vm8N25mN_6fRwSyFQwCoMGqxvZZVIPZjB3G0jhrUYVBEOxni07nqqdH5JA~490e7ae555eb1e8f963abcff6a7e2425

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
599 JPY
Average target price
1,800 JPY
Spread / Average Target
+200.50%
High Price Target
1,800 JPY
Spread / Highest target
+200.50%
Low Price Target
1,800 JPY
Spread / Lowest Target
+200.50%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 4579 Stock
  4. Consensus RaQualia Pharma Inc.